Cargando…
Underexpression of Carbamoyl Phosphate Synthetase I as Independent Unfavorable Prognostic Factor in Intrahepatic Cholangiocarcinoma: A Potential Theranostic Biomarker
Intrahepatic cholangiocarcinoma (IHCC) is the second most common malignant neoplasm of the liver. In spite of the increasing incidence worldwide, it is relatively rare in Western countries. IHCC is relatively common in Eastern and Southeastern Asia. Patients with IHCC are usually diagnosed at an adv...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10340233/ https://www.ncbi.nlm.nih.gov/pubmed/37443694 http://dx.doi.org/10.3390/diagnostics13132296 |
_version_ | 1785072029671620608 |
---|---|
author | Ong, Khaa Hoo Hsieh, Yao-Yu Sun, Ding-Ping Huang, Steven Kuan-Hua Tian, Yu-Feng Chou, Chia-Ling Shiue, Yow-Ling Joseph, Keva Chang, I-Wei |
author_facet | Ong, Khaa Hoo Hsieh, Yao-Yu Sun, Ding-Ping Huang, Steven Kuan-Hua Tian, Yu-Feng Chou, Chia-Ling Shiue, Yow-Ling Joseph, Keva Chang, I-Wei |
author_sort | Ong, Khaa Hoo |
collection | PubMed |
description | Intrahepatic cholangiocarcinoma (IHCC) is the second most common malignant neoplasm of the liver. In spite of the increasing incidence worldwide, it is relatively rare in Western countries. IHCC is relatively common in Eastern and Southeastern Asia. Patients with IHCC are usually diagnosed at an advanced stage, therefore, the clinical outcome is dismal. Dysregulation of urea cycle metabolic enzyme expression is found in different types of cancers. Nevertheless, a comprehensive evaluation of genes related to the urea cycle (i.e., GO:0000050) has not been conducted in IHCC. By performing a comparative analysis of gene expression profiles, we specifically examined genes associated with the urea cycle (GO:0000050) in a publicly accessible transcriptomic dataset (GSE26566). Interestingly, CPS1 was identified as the second most prominently down-regulated gene in this context. Tumor tissues of 182 IHCC patients who underwent curative-intent hepatectomy were enrolled. The expression level of CPS1 protein in our IHCC cohort was assessed by immunohistochemical study. Subsequent to that, statistical analyses were carried out to examine the expression of CPS1 in relation to various clinicopathological factors, as well as to assess its impact on survival outcomes. We noticed that lower immunoreactivity of CPS1 in IHCC was associated with tumor progression (pT status) with statistical significance (p = 0.003). CPS1 underexpression was not only negatively correlated to overall survival (OS), disease-free survival (DFS), local recurrence-free survival (LRFS) and metastasis-free survival (MeFS) in univariate analysis but also an independent prognosticator to forecast poorer clinical outcome for all prognostic indices (OS, DFS, LRFS and MeFs) in patients with IHCC (all p ≤ 0.001). These results support that CPS1 may play a crucial role in IHCC oncogenesis and tumor progression and serve as a novel prognostic factor and a potential diagnostic and theranostic biomarker. |
format | Online Article Text |
id | pubmed-10340233 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-103402332023-07-14 Underexpression of Carbamoyl Phosphate Synthetase I as Independent Unfavorable Prognostic Factor in Intrahepatic Cholangiocarcinoma: A Potential Theranostic Biomarker Ong, Khaa Hoo Hsieh, Yao-Yu Sun, Ding-Ping Huang, Steven Kuan-Hua Tian, Yu-Feng Chou, Chia-Ling Shiue, Yow-Ling Joseph, Keva Chang, I-Wei Diagnostics (Basel) Article Intrahepatic cholangiocarcinoma (IHCC) is the second most common malignant neoplasm of the liver. In spite of the increasing incidence worldwide, it is relatively rare in Western countries. IHCC is relatively common in Eastern and Southeastern Asia. Patients with IHCC are usually diagnosed at an advanced stage, therefore, the clinical outcome is dismal. Dysregulation of urea cycle metabolic enzyme expression is found in different types of cancers. Nevertheless, a comprehensive evaluation of genes related to the urea cycle (i.e., GO:0000050) has not been conducted in IHCC. By performing a comparative analysis of gene expression profiles, we specifically examined genes associated with the urea cycle (GO:0000050) in a publicly accessible transcriptomic dataset (GSE26566). Interestingly, CPS1 was identified as the second most prominently down-regulated gene in this context. Tumor tissues of 182 IHCC patients who underwent curative-intent hepatectomy were enrolled. The expression level of CPS1 protein in our IHCC cohort was assessed by immunohistochemical study. Subsequent to that, statistical analyses were carried out to examine the expression of CPS1 in relation to various clinicopathological factors, as well as to assess its impact on survival outcomes. We noticed that lower immunoreactivity of CPS1 in IHCC was associated with tumor progression (pT status) with statistical significance (p = 0.003). CPS1 underexpression was not only negatively correlated to overall survival (OS), disease-free survival (DFS), local recurrence-free survival (LRFS) and metastasis-free survival (MeFS) in univariate analysis but also an independent prognosticator to forecast poorer clinical outcome for all prognostic indices (OS, DFS, LRFS and MeFs) in patients with IHCC (all p ≤ 0.001). These results support that CPS1 may play a crucial role in IHCC oncogenesis and tumor progression and serve as a novel prognostic factor and a potential diagnostic and theranostic biomarker. MDPI 2023-07-06 /pmc/articles/PMC10340233/ /pubmed/37443694 http://dx.doi.org/10.3390/diagnostics13132296 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Ong, Khaa Hoo Hsieh, Yao-Yu Sun, Ding-Ping Huang, Steven Kuan-Hua Tian, Yu-Feng Chou, Chia-Ling Shiue, Yow-Ling Joseph, Keva Chang, I-Wei Underexpression of Carbamoyl Phosphate Synthetase I as Independent Unfavorable Prognostic Factor in Intrahepatic Cholangiocarcinoma: A Potential Theranostic Biomarker |
title | Underexpression of Carbamoyl Phosphate Synthetase I as Independent Unfavorable Prognostic Factor in Intrahepatic Cholangiocarcinoma: A Potential Theranostic Biomarker |
title_full | Underexpression of Carbamoyl Phosphate Synthetase I as Independent Unfavorable Prognostic Factor in Intrahepatic Cholangiocarcinoma: A Potential Theranostic Biomarker |
title_fullStr | Underexpression of Carbamoyl Phosphate Synthetase I as Independent Unfavorable Prognostic Factor in Intrahepatic Cholangiocarcinoma: A Potential Theranostic Biomarker |
title_full_unstemmed | Underexpression of Carbamoyl Phosphate Synthetase I as Independent Unfavorable Prognostic Factor in Intrahepatic Cholangiocarcinoma: A Potential Theranostic Biomarker |
title_short | Underexpression of Carbamoyl Phosphate Synthetase I as Independent Unfavorable Prognostic Factor in Intrahepatic Cholangiocarcinoma: A Potential Theranostic Biomarker |
title_sort | underexpression of carbamoyl phosphate synthetase i as independent unfavorable prognostic factor in intrahepatic cholangiocarcinoma: a potential theranostic biomarker |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10340233/ https://www.ncbi.nlm.nih.gov/pubmed/37443694 http://dx.doi.org/10.3390/diagnostics13132296 |
work_keys_str_mv | AT ongkhaahoo underexpressionofcarbamoylphosphatesynthetaseiasindependentunfavorableprognosticfactorinintrahepaticcholangiocarcinomaapotentialtheranosticbiomarker AT hsiehyaoyu underexpressionofcarbamoylphosphatesynthetaseiasindependentunfavorableprognosticfactorinintrahepaticcholangiocarcinomaapotentialtheranosticbiomarker AT sundingping underexpressionofcarbamoylphosphatesynthetaseiasindependentunfavorableprognosticfactorinintrahepaticcholangiocarcinomaapotentialtheranosticbiomarker AT huangstevenkuanhua underexpressionofcarbamoylphosphatesynthetaseiasindependentunfavorableprognosticfactorinintrahepaticcholangiocarcinomaapotentialtheranosticbiomarker AT tianyufeng underexpressionofcarbamoylphosphatesynthetaseiasindependentunfavorableprognosticfactorinintrahepaticcholangiocarcinomaapotentialtheranosticbiomarker AT chouchialing underexpressionofcarbamoylphosphatesynthetaseiasindependentunfavorableprognosticfactorinintrahepaticcholangiocarcinomaapotentialtheranosticbiomarker AT shiueyowling underexpressionofcarbamoylphosphatesynthetaseiasindependentunfavorableprognosticfactorinintrahepaticcholangiocarcinomaapotentialtheranosticbiomarker AT josephkeva underexpressionofcarbamoylphosphatesynthetaseiasindependentunfavorableprognosticfactorinintrahepaticcholangiocarcinomaapotentialtheranosticbiomarker AT changiwei underexpressionofcarbamoylphosphatesynthetaseiasindependentunfavorableprognosticfactorinintrahepaticcholangiocarcinomaapotentialtheranosticbiomarker |